Enzon Pharmaceuticals Inc (ENZN)
0.075
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Enzon Pharmaceuticals 1 Year Total Returns (Daily): -65.91% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -65.91% |
May 02, 2024 | -65.91% |
May 01, 2024 | -58.63% |
April 30, 2024 | -59.29% |
April 29, 2024 | -59.29% |
April 26, 2024 | -59.54% |
April 25, 2024 | -57.07% |
April 24, 2024 | -62.64% |
April 23, 2024 | -63.73% |
April 22, 2024 | -66.34% |
April 19, 2024 | -64.70% |
April 18, 2024 | -66.36% |
April 17, 2024 | -66.36% |
April 16, 2024 | -68.54% |
April 15, 2024 | -63.69% |
April 12, 2024 | -54.90% |
April 11, 2024 | -59.05% |
April 10, 2024 | -53.98% |
April 09, 2024 | -61.55% |
April 08, 2024 | -66.82% |
April 05, 2024 | -70.86% |
April 04, 2024 | -71.99% |
April 03, 2024 | -75.00% |
April 02, 2024 | -76.15% |
April 01, 2024 | -69.90% |
Date | Value |
---|---|
March 28, 2024 | -57.72% |
March 27, 2024 | -57.62% |
March 26, 2024 | -67.49% |
March 25, 2024 | -72.30% |
March 22, 2024 | -68.18% |
March 21, 2024 | -61.96% |
March 20, 2024 | -70.71% |
March 19, 2024 | -75.49% |
March 18, 2024 | -66.18% |
March 15, 2024 | -66.85% |
March 14, 2024 | -67.32% |
March 13, 2024 | -66.58% |
March 12, 2024 | -66.47% |
March 11, 2024 | -72.39% |
March 08, 2024 | -72.55% |
March 07, 2024 | -68.53% |
March 06, 2024 | -69.57% |
March 05, 2024 | -66.88% |
March 04, 2024 | -73.96% |
March 01, 2024 | -69.02% |
February 29, 2024 | -74.39% |
February 28, 2024 | -72.98% |
February 27, 2024 | -69.91% |
February 26, 2024 | -67.92% |
February 23, 2024 | -68.37% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-76.15%
Minimum
Apr 02 2024
406.5%
Maximum
Apr 08 2021
23.37%
Average
-5.18%
Median
Feb 01 2022
1 Year Total Returns (Daily) Benchmarks
AIM ImmunoTech Inc | -15.65% |
Perspective Therapeutics Inc | 196.0% |
Protalix BioTherapeutics Inc | -63.81% |
Electromed Inc | 78.40% |
Armata Pharmaceuticals Inc | 61.69% |